Both liposomal NAD+ and NMN supplements aim to raise NAD+ levels in the body to support healthy aging.
The major difference between the two is that NMN has stronger human clinical evidence as an effective oral NAD+ booster, while liposomal NAD+ relies more on its delivery method and early data than on long-term outcomes.
Liposomal supplements wrap an ingredient, in this case NAD, inside tiny fat-based spheres (liposomes). The goal of this technology is to prevent the compound from breaking down in the digestive tract, thereby improving its absorption into the bloodstream. NAD on its own is notoriously difficult to absorb, and compared to NMN, it’s a much larger molecule that has to be broken down into smaller parts before it can be absorbed into the cells to increase NAD levels.
And while the goal is to increase overall NAD levels, researchers believe that precursors are the most efficient way to do this. NMN is the direct precursor to NAD+. It’s more readily absorbed by the cells and is converted into NAD+. Though it might seem more efficient to take NAD directly, it’s actually the opposite, as NAD requires more steps before it’s absorbed into the cell.
Liposomal NAD+ vs NMN: Side-by-Side Comparison
NMN reliably converts to NAD+ through well-studied biological pathways, while liposomal NAD+ focuses on delivering NAD+ into the bloodstream via enhanced absorption technology, though with far less human clinical validation.
We’ve outlined a side-by-side comparison of liposomal NAD+ and NMN.
We’re not trying to highlight one over the other, but wanted to make it easier to see where these two options overlap and where the differences actually matter when choosing an NAD+ support supplement.
|
Feature |
NMN (Standard or Liposomal) |
Liposomal NAD |
|
What is it? |
Direct NAD+ precursor |
The finished NAD molecule is encapsulated in liposomes to improve delivery |
|
Role in the body |
Converts into NAD+ via the salvage pathway |
Used directly as NAD in the bloodstream. Needs to be broken down into NMN, NR, or NAM before entering the cell to form NAD again |
|
Oral stability |
Reasonably stable as capsules, powder, gummies, and tablets |
Poor stability as NAD unless in liposomal format |
|
Human clinical data |
Multiple RCTs |
Very limited |
|
NAD+ biomarker increases |
Consistently shown |
Shown vs regular NAD+, not vs NMN |
|
Evidence strength |
Strong |
Early/Emerging |
|
Typical use |
Long-term NAD+ support |
Niche or adjunct use |
What The Research Actually Says: NMN vs. Liposomal NAD
NMN is currently one of the best-studied oral NAD+ boosters available.
Human trials (typically 250–900 mg/day for 4–12 weeks) show that NMN raises whole-blood NAD+ and related metabolites, with good tolerability, and even hints at functional health benefits such as improved muscle performance, walking endurance, and healthier overall cardiovascular function [1].
A simple way to think about it is that NMN acts like delivering high-quality building materials to a factory your body already knows how to run: instead of forcing the finished product through the door, you’re supplying the exact components needed so cells can reliably make their own NAD+ and keep operations running smoothly.
Oral NAD+ without liposomal protection is poorly absorbed and breaks down quickly in the gut. Liposomal encapsulation improves that, but how much it helps in the long term is still unknown.
A 2025 human pharmacokinetic study sponsored by EffePharm tested a branded liposomal NAD+ product (LipoAvail) against a standard oral NAD+ supplement and showed ~1.5× higher NAD+ exposure (AUC and Cmax) with liposomal NAD+ [2].
This study confirms that liposomal NAD+ is better absorbed than regular NAD+, but it did not compare liposomal NAD+ to NMN or measure long-term functional outcomes.
When Each Supplement Might Make Sense: Lipsomal NAD vs NMN
If you’re looking for something with human research behind it, NMN — whether regular or liposomal — is usually the easier choice.
NMN has been studied more and has been shown to reliably raise NAD+ levels, and it tends to be more budget-friendly than the other option.
Liposomal NAD+ is more of a “try it and see” option for people who like the idea of taking NAD+ directly, especially if they’re already using things like IV or nasal NAD+ and want an oral add-on. Neither one is wrong. It really comes down to whether you value solid track-record data or are more curious about newer delivery methods.
Resources:
-
Yi, L., Maier, A. B., Tao, R., Lin, Z., Vaidya, A., Pendse, S., ... & Kumbhar, V. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. Geroscience, 45(1), 29-43.
-
EffePharm. (2025, October 15). Liposomal NAD+: The latest human clinical trial proves a 1.5× absorption breakthrough. https://effepharm.com/liposomal-nad-the-latest-human-clinical-trial-proves-a-1-5x-absorption-breakthrough
